Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease

CEA, CA19-9 and CA50 are tumour associated antigens defined by monoclonal antibodies which have been raised against adenocarcinoma cell lines. The aim of this study was to determine whether their combined use could improve diagnostic accuracy in patients with primary and secondary liver tumours. An...

詳細記述

保存先:
書誌詳細
主要な著者: Lucarotti, M. E., Rothnie, N. D., Kelly, S. B., Hershman, M. J., Johanssen, C., Nilsson, O., Lindholm, L., Wood, C. B., Williamson, R. C. N., Habib, N. A.
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 1991
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442938/
https://ncbi.nlm.nih.gov/pubmed/1777407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/1991/23874
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料